Gleevec Fights Rare Stomach Cancer
Gleevec Fights Rare Stomach Cancer
'Smart Bomb' Leukemia Drug Finding New Targets
In a second study in the journal, researchers found that Gleevec also works well for people with a cancer-like condition of bone marrow called chronic myeloproliferative disease. However, since Gleevec works specifically on one gene abnormality, the drug was tested only in people who had this gene mutation. The four participants in the study all had improvements that lasted for 9 to 12 months. More study is needed to see if the response will last longer.
Gleevec Fights Rare Stomach Cancer
'Smart Bomb' Leukemia Drug Finding New Targets
In a second study in the journal, researchers found that Gleevec also works well for people with a cancer-like condition of bone marrow called chronic myeloproliferative disease. However, since Gleevec works specifically on one gene abnormality, the drug was tested only in people who had this gene mutation. The four participants in the study all had improvements that lasted for 9 to 12 months. More study is needed to see if the response will last longer.
